Bone Biologics Corp (BBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,566 | 2,332 | 3,228 | 3,027 | 4,453 |
| Other current assets | 386 | 650 | 329 | 329 | 0 |
| TOTAL | $4,066 | $3,194 | $3,840 | $3,738 | $4,976 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $4,066 | $3,194 | $3,840 | $3,738 | $4,976 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 190 | 232 | 146 | 361 | 1,103 |
| Accrued Expenses | N/A | N/A | N/A | 415 | N/A |
| Other current liabilities | 83 | 53 | 18 | 56 | 81 |
| TOTAL | $273 | $285 | $165 | $831 | $1,183 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $273 | $285 | $165 | $831 | $1,183 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 411 | 300 | 183 | 89 | 65 |
| Common Shares | 2 | 1 | 1 | 1 | 3 |
| Retained earnings | -83,500 | -82,559 | -81,775 | -80,909 | -79,359 |
| TOTAL | $3,792 | $2,909 | $3,675 | $2,906 | $3,793 |
| Total Liabilities And Equity | $4,066 | $3,194 | $3,840 | $3,738 | $4,976 |